131462
Research payments
$654,033
Through program year 2025, $654,033 in research payments was reported against 131462, across 51 payments, paid by Iovance Biotherapeutics, Inc..
- Paid by
- Iovance Biotherapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $512,328 | 48 |
| 2024 | Research | $141,705 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Koji Matsuo Baltimore, MD Named on 10 payments
- Jason Chesney Louisville, KY Named on 8 payments
- Kathleen Moore Oklahoma City, OK Named on 8 payments
- Tirrell Johnson Orlando, FL Named on 6 payments
- Robert Morris Detroit, MI Named on 5 payments
- Katherine Mager Buffalo, NY Named on 4 payments
- Robert Wenham Tampa, FL Named on 3 payments
- David Starks Sioux Falls, SD Named on 3 payments
- Amir Jazaeri Houston, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.